Should I buy or sell Prenetics Global stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prenetics Global in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRE shares. View PRE analyst ratings or view top-rated stocks .

What is Prenetics Global's stock price target for 2024?

1 brokerages have issued twelve-month price objectives for Prenetics Global's stock. Their PRE share price targets range from $9.00 to $9.00. On average, they predict the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 184.8% from the stock's current price. View analysts price targets for PRE or view top-rated stocks among Wall Street analysts .

How have PRE shares performed in 2024?

Prenetics Global's stock was trading at $5.91 at the start of the year. Since then, PRE stock has decreased by 46.5% and is now trading at $3.16. View the best growth stocks for 2024 here .

Are investors shorting Prenetics Global?

Prenetics Global saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 12,800 shares, an increase of 60.0% from the March 15th total of 8,000 shares. Based on an average daily volume of 69,600 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the stock are sold short. View Prenetics Global's Short Interest .

When is Prenetics Global's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024. View our PRE earnings forecast .

How were Prenetics Global's earnings last quarter?

Prenetics Global Limited (NASDAQ:PRE) announced its quarterly earnings data on Friday, September, 15th. The company reported ($0.75) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.15. The firm had revenue of $5.70 million for the quarter. Prenetics Global had a negative trailing twelve-month return on equity of 11.15% and a negative net margin of 193.60%.

When did Prenetics Global's stock split?

Prenetics Global's stock reverse split on Tuesday, November 14th 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

How do I buy shares of Prenetics Global?

Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:PRE

Prenetics Global (PRE) Stock Price, News & Analysis

→ Emergency: Biden's $20 Trillion Mistake Could Cost YOU! (From GoldenCrest Metals) (Ad)

Free PRE Stock Alerts

$3.14

-0.01 (-0.32%)

(As of 01:35 PM ET)

Compare

Today's Range: $3.14
▼
$3.32
50-Day Range: $3.15
▼
$5.67
52-Week Range: $3.13
▼
$15.90

Volume: 65,345 shs
Average Volume: 70,530 shs
Market Capitalization: $28.70 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $9.00

Get Prenetics Global alerts:

Prenetics Global MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 184.8% Upside
$9.00 Price Target
Short Interest: Healthy
0.17% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.07 out of 5 stars

Medical Sector

782nd out of 914 stocks

Holding & Other Investment Offices Industry

9th out of 10 stocks

3.5

Analyst's Opinion

Consensus Rating
Prenetics Global has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Prenetics Global has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.17% of the float of Prenetics Global has been sold short.
Short Interest Ratio / Days to Cover
Prenetics Global has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Prenetics Global has recently increased by 60.00%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Prenetics Global does not currently pay a dividend.
Dividend Growth
Prenetics Global does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PRE.

0.6

News and Social Media Coverage

Search Interest
6 people have searched for PRE on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Prenetics Global insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 7.80% of the stock of Prenetics Global is held by insiders.
Percentage Held by Institutions
Only 25.01% of the stock of Prenetics Global is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Prenetics Global is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Prenetics Global is -0.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Prenetics Global has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad GoldenCrest Metals

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

Learn More Now

About Prenetics Global Stock (NASDAQ:PRE)

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

PRE Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PRE Stock News Headlines

April 6, 2024 | benzinga.com

Prenetics Global Stock (NASDAQ:PRE), Analyst Ratings, Price Targets, Predictions

April 3, 2024 | baystreet.ca

Prenetics Flat on Financial Results

April 18, 2024 | GoldenCrest Metals (Ad)

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

April 1, 2024 | finanznachrichten.de

Prenetics Global Limited: Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

April 1, 2024 | benzinga.com

Prenetics Global: Q4 Earnings Insights

April 1, 2024 | investorplace.com

PRE Stock Earnings: Prenetics Global Beats EPS, Misses Revenue for Q4 2023

April 1, 2024 | globenewswire.com

Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results

February 9, 2024 | finance.yahoo.com

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

April 18, 2024 | GoldenCrest Metals (Ad)

Exposed: How Big Banks Plan to Chain Your Wealth with Digital Dollars

Big Banks have declared war on your wallet. But it's not too late to fight back. Discover how to protect your assets from their latest maneuver.

February 9, 2024 | globenewswire.com

Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station

January 17, 2024 | msn.com

Prenetics Global files to sell 1.48M Class A shares for holders

December 18, 2023 | investing.com

Prenetics Global (PRE) Earnings Dates & Reports

December 17, 2023 | seekingalpha.com

PRENW Prenetics Global Limited WT EXP 051827

November 20, 2023 | benzinga.com

Prenetics Global Stock (NASDAQ:PRE) Insider Trades

November 20, 2023 | msn.com

Prenetics Global GAAP EPS of -$0.08, revenue of $4.86M

November 20, 2023 | benzinga.com

Prenetics Global: Q3 Earnings Insights

November 20, 2023 | finance.yahoo.com

Prenetics Announces Third Quarter 2023 Financial Results

November 11, 2023 | finance.yahoo.com

Prenetics Global Limited (NASDAQ:PRE): Is Breakeven Near?

November 5, 2023 | morningstar.com

Prenetics Global Ltd Class A PRE

November 1, 2023 | msn.com

Prenetics Global announces reverse stock split

November 1, 2023 | finance.yahoo.com

Prenetics Global Limited Announces Reverse Stock Split

October 30, 2023 | money.usnews.com

Prenetics Global Limited - Ordinary Shares - Class A

October 3, 2023 | finance.yahoo.com

Genetic Genealogy Market | Direct-To-Customer Segment Registered The Highest Growth - Here's Why

September 15, 2023 | finanznachrichten.de

Prenetics Global Limited: Prenetics Announces Second Quarter 2023 Financial Results

September 15, 2023 | finance.yahoo.com

Prenetics Announces Second Quarter 2023 Financial Results

September 10, 2023 | finance.yahoo.com

PRE - Prenetics Global Limited

August 29, 2023 | finance.yahoo.com

A World's First: The Miss Hong Kong Pageant 2023 Unveiled Contestants' CircleDNA Results Live on Television

See More Headlines

Receive PRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prenetics Global and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 9/15/2023
Today: 4/18/2024
Next Earnings (Estimated): 6/03/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Holding & other investment offices
Sub-Industry: N/A
Current Symbol: NASDAQ:PRE
CUSIP: N/A
CIK: 1876431
Web: www.prenetics.com
Phone: 852-2210-9588
Fax: N/A
Employees: 400
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $9.00
High Stock Price Target: $9.00
Low Stock Price Target: $9.00
Potential Upside/Downside: +185.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($4.7985)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-62,720,000.00
Net Margins: -193.60%
Pretax Margin: -260.63%
Return on Equity: -11.15%
Return on Assets: -9.03%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.37
Quick Ratio: 2.29

Sales & Book Value

Annual Sales: $21.74 million
Price / Sales: 1.32
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $23.00 per share
Price / Book: 0.14

Miscellaneous

Outstanding Shares: 9,140,000
Free Float: 8,424,000
Market Cap: $28.79 million
Optionable: Not Optionable
Beta: -0.11

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Sheng Wu Yeung (Age 45)
Co-Founder & CEO
Dr. Chi Hung Tzang Ph.D. (Age 49)
Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board
Mr. Hoi Chun Lo (Age 39)
Chief Financial Officer
Dr. Yung Ho Wong DPHIL (Age 42)
Chief Technology Officer
Ms. Yvonne L. Wong
Chief Corporate Development Officer
Ms. Samantha Kwok
Vice President People & Culture
Dr. Senthil Sundaram M.D. (Age 50)
Chief Clinical Officer
Mr. Avrom Boris Lasarow (Age 47)
Chief Executive Officer of EMEA
Dr. Shih-Chang Ong M.D. (Age 46)
Chief Medical Officer & Member of Scientific Advisory Board
Mr. Joel Neoh
Chief Consumer Officer & MD for CircleDNA

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

PRE Stock Analysis - Frequently Asked Questions

Should I buy or sell Prenetics Global stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prenetics Global in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRE shares.
View PRE analyst ratings or view top-rated stocks.
What is Prenetics Global's stock price target for 2024?: 1 brokerages have issued twelve-month price objectives for Prenetics Global's stock. Their PRE share price targets range from $9.00 to $9.00. On average, they predict the company's stock price to reach $9.00 in the next twelve months. This suggests a possible upside of 184.8% from the stock's current price.
View analysts price targets for PRE or view top-rated stocks among Wall Street analysts.
How have PRE shares performed in 2024?: Prenetics Global's stock was trading at $5.91 at the start of the year. Since then, PRE stock has decreased by 46.5% and is now trading at $3.16.
View the best growth stocks for 2024 here.
Are investors shorting Prenetics Global?: Prenetics Global saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 12,800 shares, an increase of 60.0% from the March 15th total of 8,000 shares. Based on an average daily volume of 69,600 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the stock are sold short.
View Prenetics Global's Short Interest.

When is Prenetics Global's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, June 3rd 2024.
View our PRE earnings forecast.
How were Prenetics Global's earnings last quarter?: Prenetics Global Limited (NASDAQ:PRE) announced its quarterly earnings data on Friday, September, 15th. The company reported ($0.75) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.90) by $0.15. The firm had revenue of $5.70 million for the quarter. Prenetics Global had a negative trailing twelve-month return on equity of 11.15% and a negative net margin of 193.60%.
When did Prenetics Global's stock split?: Prenetics Global's stock reverse split on Tuesday, November 14th 2023. The 1-15 reverse split was announced on Wednesday, November 1st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
How do I buy shares of Prenetics Global?: Shares of PRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PRE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Prenetics Global (PRE) Stock Price, News & Analysis

Prenetics Global MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

Company Ownership

Earnings and Valuation

About Prenetics Global Stock (NASDAQ:PRE)

PRE Stock Price History

PRE Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

PRE Stock Analysis - Frequently Asked Questions

Overall MarketRank^™